A new RSV shot could help protect babies this winter — if they can get it in time

Emily Bendt was in her third trimester of pregnancy when she first heard the Centers for Disease Control and Prevention had approved a new shot for infants to protect them from the respiratory syncytial virus, or RSV.

AstraZeneca’s Imfinzi combo extends PFS in liver cancer; Novartis shares new details about Lutathera’s PhIII

Here are the latest data from ASCO’s Gastrointestinal Cancers Symposium: Imfinzi combo extends progression-free survival in liver cancer: In a Phase III trial, AstraZeneca’s Imfinzi

January 20, 2024

Pharmalittle: We’re reading about Medicare drug prices, a Sanofi MS pill, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on our side of the pond —

September 3, 2024

Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets

Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced “substantial and durable” overall and intracranial clinical activity in patients with HER2-positive advanced breast cancer, according to data from

September 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.